Precision diagnosis of lupus nephritis: opportunities and role of biomarkers
Journal Title: Нирки - Year 2019, Vol 8, Issue 2
Abstract
The most common complication in patients with systemic lupus erythematosus is lupus nephritis (LN), a condition that can lead to end-stage kidney disease. In recent years, many serum and urine biomarkers, genetic studies have been proposed for the diagnosis of LN, but none of them entered into guidelines for clinical use. The majority of studies have been single-center with significant variability in cohorts, assays, and sample storage, leading to inconclusive results. It has become clear that no single biomarker is likely to be sufficient to diagnose LN, identify flares, and define the response to therapy and prognosis. A more likely scenario for future diagnostics is a panel of biomarkers for urine, serum, kidney tissue, and genetic biomarkers. The review summarizes the data on traditional and new serum, urinary and genetic biomarkers, discusses the feasibility of their use in clinical practice and the possibility of implementation for a more accurate diagnosis of LN. Each “panel” of biomarkers will provide a unique understanding of the various clinical issues of disease development and progression. Thus, the genetic panel can determine the likelihood of nephritis in a patient with systemic lupus erythematosus and which inflammatory pathways will be involved in the LN development. A urine biomarker panel can help distinguish between inflammation and fibrosis, eliminating the need for repeated biopsies. A serum biomarker panel can identify nephritogenic autoantibodies that increase the number of exacerbations, cause their severity and worsen the response to treatment. A more systematic and focused approach to the study of biomarkers will allow precision diagnosis to become a reality for patients with LN.
Authors and Affiliations
I. Yu. Golovach, Ye. D. Yehudina
Modern Philosophy of Knowledge Transfer in Postgraduate Medical Education
.
Nephropathy in antiphospholipid syndrome.
Lecture "Nephropathy in antiphospholipid syndrome" is recommended for postgraduate education for nephrologists, physicians, obstetricians and gynaecologists, rheumatologists.
Changes in Renal Vascular Endothelium and Indicators of Endothelial Vascular Dysfunction in Systemic Autoimmune Rheumatic Diseases
Background. The renal endothelium is the primary barrier which reacts to systemic endothelial vascular dysfunction in patients with rheumatic diseases. The objective of the work was to evaluate the nature of morphologica...
Renal Artery Stenosis of the Transplanted Kidney
The article describes the results of observation of the patient with stenosis of the main artery of the transplanted kidney before and after balloon dilation of stenosis. The kidney was studied by Ultrasound, Doppler and...
24-hour blood pressure profile in children with chronic pyelonephritis and chronic kidney disease stages I–III
Background. Blood pressure (BP) monitoring is important for the management of patients with chronic kidney disease (CKD), both for the conventional cardiovascular risk reduction and long-term preservation of kidney funct...